Victoria Mudd, APRN
Family · Shepherdsville, KYNPI 1174240089
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 24.8% of the total.
Across 159 payments — averaging $14.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$553
- AbbVie$515
- Pfizer$105
- AstraZeneca$104
- Astellas Pharma US Inc$101
- Axsome Therapeutics, Inc.$87
- plus $763 from 16 others
What the payments were for
- Food & beverage$2,228100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $553 |
| AbbVie | 50 | $515 |
| Pfizer | 7 | $105 |
| AstraZeneca | 7 | $104 |
| Astellas Pharma US Inc | 6 | $101 |
| Axsome Therapeutics, Inc. | 6 | $87 |
| Boehringer Ingelheim | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Johnson & Johnson | 4 | $69 |
| Corcept Therapeutics | 3 | $65 |
| Lilly USA, LLC | 4 | $59 |
| Merck | 3 | $54 |
| Exact Sciences | 3 | $54 |
| GSK | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 3 | $49 |
| Bayer | 3 | $47 |
| Lundbeck LLC | 2 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Biogen | 1 | $17 |
| Averitas Pharma Inc. | 1 | $15 |
| Novartis | 1 | $13 |
How this compares
$2,228 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 26 | $801 |
| Levothyroxine Sodium | 33 | $490 |
| Lisinopril | 70 | $419 |
| Metformin Hcl ErMetformin Hcl | 11 | $416 |
| Atorvastatin Calcium | 36 | $370 |
| Bupropion XlBupropion Hcl | 11 | $350 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $295 |
| Montelukast Sodium | 15 | $210 |
| Simvastatin | 24 | $192 |
| Pantoprazole Sodium | 18 | $166 |
| Amitriptyline Hcl | 15 | $163 |
| Trazodone Hcl | 23 | $155 |
| Metformin Hcl | 21 | $153 |
| Metoprolol Succinate | 14 | $149 |
| Escitalopram Oxalate | 12 | $136 |
Paid to pharmacies, not to this prescriber.
Other family in Shepherdsville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
- Carrie Parrish NyekanBowling Green$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.